“Very good news for #Cuba and #Mexico. Our vaccine #Abdala, of proven efficacy, continues to insert itself in the world. This Emergency Use Authorization is a recognition of the talent and dedication of Cuban scientists,” the President wrote on Twitter.
On Wednesday, Cuba’s Biotechnology and Pharmaceutical Industries Group (BioCubafarma) reported on social media that, with this approval, Mexico can import the Abdala vaccine for use in the National Vaccination campaign against the SARS-CoV-2 virus in people over 19 years of age.
The immunogen, developed by scientists at the island’s Center for Genetic Engineering and Biotechnology, is 92.8% effective against the coronavirus, in a three-dose schedule, according to information from the institution.
Cuba developed five vaccine candidates against the coronavirus: Abdala, Soberana 01, Soberana 02, Soberana Plus and Mambisa, of which Abdala, Soberana 02 and Soberana Plus have already been approved and are vaccines with which the nation has immunized more than 90 percent of its population.